Online
|
|
NSE Announcements on Glenmark
Posted by :
MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange vide its letter dated October 29, 2009 that "At the meeting of the Board of Directors held today, the Board has approved the conversion of 64,100 stock options issued to its employees into 64,100 Equity Shares pursuant to the ESOS 2003"....
BSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2009, has approved the conversion of 64,100 stock options issued to its employees into 64,100 Equity Shares pursuant to the ESOS 2003....
BSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd has submitted to BSE a copy of the Management Discussion and Analysis for the Second quarter of the Financial Year 2009-10....
GLENMARK Q2 Numbers Out
Posted by : pms.swastika
GLENMARK Q2 Numbers Out:
Standalone net Sales at Rs. 235.83 Cr Vs Rs. 225.85 Cr (+4.42%) (YoY)
Standalone Net Profit at Rs. 57.50 Cr Vs Rs. 66.89 Cr (-14.04%) (YoY)
Regards
Swastika PMS...
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated October 29, 2009, titled "Glenmarks consolidated revenue increases by 5% to Rs. 5903.26 Mn for Q2-FY10. Consolidated Net Profit at Rs. 808.85 million". The Company has further submitted to the Exchange a copy of the Management Discussion and Analysis for the second quarter of the Financial Year 2009-10 ended September 30, 2009. The copies of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 23583.48 lacs for quarter ending on 30-SEP-2009 against Rs. 22585.42 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 5750.18 lacs for the quarter ending on 30-SEP-2009 against Rs. 6688.67 lacs for the quarter ending on 30-SEP-2008....
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 45579.4 lacs for half year ending on 30-SEP-2009 against Rs. 41982.93 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 6272.18 lacs for the half year ending on 30-SEP-2009 against Rs. 12372.24 lacs for the half year ending on 30-SEP-2008....
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 59032.61 lacs for quarter ending on 30-SEP-2009 against Rs. 55971.93 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 8088.51 lacs for the quarter ending on 30-SEP-2009 against Rs. 11736.01 lacs for the quarter ending on 30-SEP-2008....
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 113401.36 lacs for half year ending on 30-SEP-2009 against Rs. 102054.42 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 13433.96 lacs for the half year ending on 30-SEP-2009 against Rs. 23273.69 lacs for the half year ending on 30-SEP-2008....
BSE Announcements on Glenmark
Posted by : MMB Messenger
Glenmark Pharmaceuticals Ltd has informed BSE regarding Press Release dated October 29, 2009 titled "Glenmarks consolidated revenue increases by 5 % to Rs. 5903.26 Mn for Q2-
FY10. Consolidated Net Profit at Rs. 808.85 million"....
BSE Announcements on Glenmark
Posted by : MMB Messenger
Glenmark Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended September 30, 2009:
The results for the Quarter ended September 30, 2009
The Company has posted a net profit after tax of Rs 575.018 million for the quarter ended September 30, 2009 as compared to Rs 668.867 million for the quarter ended September 30, 2008. Total Income has decreased from Rs 2513.705 million for the quarter ended September 30, 2008 to Rs 2387.133 million for the quarter ended September 30, 2009.
The Consolidated results are as follows:
The consolidated results for the Quarter ended September 30, 2009
The Group has posted a net profit after tax of Rs 808.851 million for the quarter ended September 30, 2009 as compared to Rs 1173.601 million for the quarter ended September 30, 2008. Total Income has increased from Rs 6042.114 million for the quarter ended September 30, 2008 to Rs 6165.571 million for the quarter ended September 30, 2009....
sell
Posted by : NAUGHTY007
26 Oct 2009 20:55
down
Posted by : NAUGHTY007
Price when posted : BSE: Rs 230.30 ( -1.75 % ), NSE: Rs. 229.85 ( -2.25 % )
View full discussion
as predicted down -buy below 210 only... ...
Heading
Posted by : NAUGHTY007
26 Oct 2009 20:55
down
Posted by : NAUGHTY007
Price when posted : BSE: Rs 230.30 ( -1.75 % ), NSE: Rs. 229.85 ( -2.25 % )
View full discussion
as predicted down -buy below 210 only... ...
BSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated October 27, 2009 titled "Glenmark Generics Europe announces the launch of its first Four Products for the UK market"...
NSE Announcements on Glenmark
Posted by : MMB MessengerGlenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated October 27, 2009, titled "Glenmark Generics Europe announces the launch of its first Four Products for the UK market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
